Natural Killer Cells Therapeutics Market Trends & Forecast 2032

Natural Killer Cells Therapeutics Market: Industry Perspective

The global natural killer cells therapeutics market size was worth around USD 2.79 Billion in 2023 and is predicted to grow to around USD 7.85 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 12.2% between 2024 and 2032. The report analyzes the global natural killer cells therapeutics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the natural killer cells therapeutics industry.

Request Free Sample

The report covers forecast and analysis for the natural killer cells therapeutics market on a global and regional level. The study provides historical data from 2018 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the natural killer cells therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the natural killer cells therapeutics market on a global as well as regional level.

Request Free Sample

In order to give the users of this report a comprehensive view on the natural killer cells therapeutics market we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides a company market share analysis in order to give a broader overview of the key players in the natural killer cell therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new therapeutics launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the natural killer cells therapeutics market on a global and regional basis.

Natural Killer Cells Therapeutics Market: Overview

Natural killer (NK) cells are type of white blood cells (lymphocyte) that are an important part of the innate immune system. NK cells are also called as killer cells or K cells. NK cells are important in host rejection of virally infected cells and tumors. NK cells contain special proteins like perforin, and proteases in their cytoplasm and are cytotoxic in nature. Perforin forms pores in cell membrane of target cells and proteases enter through these pores to induce apoptosis.

NK cells get activated in response to macrophage-derived cytokines or interferons. NK deficient patients are highly vulnerable to the primary phases of herpes virus infection. Natural killer cells can be used as therapeutics as they generate immune responses against viral infections and malignancies.

Natural Killer Cells Therapeutics Market: Growth Factors

The demand for natural killer cells therapeutics market is driven by the increasing use of NK cells for treating viral infections, cancer, liver diseases, etc. NK cells play a crucial role in immune surveillance of tumor cells which has boosted its use in cancer therapy applications. Increasing R&D investments, and increasing awareness about immunotherapies are other factors that propel the market growth across the globe.

However poor in-vivo survival rate of NK cells, high cost, and lack of specificity may act as restraint for the market growth of natural killer cells therapeutics. Emerging markets are expected to bring new growth opportunities for major market players operating in the global natural killer cells therapeutics.

Natural Killer Cells Therapeutics Market: Segmentation Analysis

The study provides a crucial view of natural killer cells therapeutics by segmenting the market based on therapeutics, application, end user and region. All the segments of the natural killer cells therapeutics market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on therapeutics, the global natural killer cells therapeutics market is bifurcated into NK cell directed antibodies and NK cell therapies. NK cell directed antibodies therapeutics segment accounted for the largest market share in 2023 and is expected to witness rapid CAGR over the forecast period. Increasing awareness for immunotherapies and increasing R&D investments have led to increasing use and thus have accounted for the largest market share.

Based on application market is segmented into immunoproliferative disorders, gastrointestinal diseases, cancer and other applications. Among applications segment cancer dominated the market in 2023 and is projected to retain its dominance over the forecast period. Increasing cancer prevalence across the globe and growing investments in novel therapy development for treating cancer are factors that contribute to the largest market share of cancer application segment.

The end-user segment is divided into hospitals, research centers & institutes and other end users. The hospital end-user segment held the largest market share due to the increasing use of NK cell therapies for various therapeutic applications across the globe. Research centers & institutes will witness rapid growth over the forecast period.

Natural Killer Cells Therapeutics Market: Report Scope

Natural Killer Cells Therapeutics Market: Regional Analysis

North America dominated the global natural killer cell therapeutics market in 2023. The increasing prevalence of cancer, preference for immunotherapies with lesser side effects, increasing R&D investments and growing awareness are factors driving the market in this region. Europe was the second largest regional market. The presence of developed infrastructure, high unmet medical needs for treating cancer and increasing prevalence of cancer and awareness are some of the factors that boost the market growth in this region.

Latin America is expected to witness moderate growth over the forecast period. Asia Pacific region will experience rapid growth in the natural killer cells therapeutics market in the coming years. Increasing geriatric population base, growing prevalence of cancer, increasing awareness, and increasing R&D investments are factors promoting natural killer cell therapeutics market growth in Asia Pacific. Middle East and Africa will see considerable growth in the coming years.

Natural Killer Cells Therapeutics Market: Competitive Analysis

Some of the major players in the global natural killer cells therapeutics market include:

• NKT Therapeutics Inc.
• Nkarta Therapeutics Inc.
• Nantkwest Inc.
• Innate Pharma S.A.
• Glycostem Therapeutics BV
• Fortress Biotech
• Fate Therapeutics
• Celgene Corporation
• Affimed N.V.
• Ziopharm Oncology Inc.

The report segments of global natural killer cells therapeutics market as follows:

By Therapeutics Analysis

• NK Cell Directed Antibodies
• NK Cell Therapies

By Application Analysis

• Immunoproliferative Disorders
• Gastrointestinal Diseases
• Cancer
• Other Applications

By End User Analysis

• Hospitals
• Research Centers & Institutes
• Other End Users

By Region Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa